Clinical trials: sponsored by Tasly Pharmaceutical Group Co., Ltd
Hyperplasia of Mammary Glands
Efficacy and Safety of Xiangjurupining Capsule for Hyperplasia of Mammary Glands
This study will evaluate the efficacy and Safety of Xiangjurupining Capsule in the treatment of Hyperplasia of Mammary Glands(stagnation of liver-qi and phlegm).
- Trial name
- NCT06685978
- Testing
- Xiang Ju Ru Pi Ning capsule
- Where
- 27 sites in China
- Volunteers
- 430 people, healthy volunteers welcome
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd
Heart Failure
Efficacy and Safety of Jia Shen Tablets in Chronic Heart Failure
Evaluate the efficacy and safety of Jia Shen Tablets in patients with Chronic Heart Failure.
- Trial name
- NCT06669169
- Testing
- Low dose Jia Shen Tablet, High dose Jia Shen Tablet
- Where
- China
- Volunteers
- 288 people
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd
Hyperplasia of Breast
A Study of Xiangjurupining Capsule in the Treatment of Hyperplasia of Breast (Liver Stagnation and Phlegm Coagulation)
The study is to evaluate the efficacy and safety of two doses of xiangjurupining capsule in Hyperplastic disease of breast patients .
- Trial name
- NCT04229706
- Testing
- High dose Xiang Ju Ru Pi Ning capsule, Low dose Xiang Ju Ru Pi Ning capsule
- Where
- 8 sites in China
- Volunteers
- 180 people
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd
Irritable Bowel Syndrome with Diarrhea
Efficacy and Safety of Changkang Granule in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)
The aim of this study is to evaluate the efficacy and safety of Changkang granule as compared to placebo over a 8-week treatment period and explore TCM syndrome types.
- Trial name
- NCT04492787
- Testing
- Changkang Granule
- Where
- 8 sites in China
- Volunteers
- 240 people
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd
Cough
Efficacy and Safety of Susu Zhike Granules for Treating Acute Cough Due to Common Cold With Cold-cough Syndrome in Children
This protocol is designed with the aim of exploring the efficacy of Susu on shortening duration and reducing severity of cough, and observe the safety used in children.
- Trial name
- NCT04457011
- Testing
- High dose Susu Xiao'er Zhike Granules 1 bag, Middle dose Susu Xiao'er Zhike Granules 1 bag, Extremely-low dose Susu Xiao'er Zhike Granules 1 bag
- Where
- 7 sites in China
- Volunteers
- 240 people
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd
Plaque Psoriasis
Efficacy and Safety of Jiuweihuaban Pill for Treating Plaque Psoriasis
This study will evaluate the efficacy and safety of Jiuweihuaban Pill in the treatment of moderate to severe plaque psoriasis(syndrome of blood-heat ).
- Trial name
- NCT06058546
- Testing
- low dose Jiuweihuaban Pill, high dose Jiuweihuaban Pill
- Where
- 12 sites in China
- Volunteers
- 180 people
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd
NASH
HuHuangLianzonggan Capsule in Subjects With Nonalcoholic Steatohepatitis: a Phase 2 tRial(HHL-HEPAR)
This study will evaluate the efficacy and safety and the best effective dose of HuHuangLianzonggan capsule in subjects with nonalcoholic steatohepatitis.
- Trial name
- NCT05632861
- Testing
- HuHuangLianzonggan capsule
- Where
- 20 sites in China
- Volunteers
- 76 people
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd
Heart Failure
Pharmacokinetic and Pharmacodynamic of Jia Shen Tablets in Chronic Heart Failure
Evaluate the pharmacokinetic and pharmacodynamic characteristics of Jia Shen Tablets in patients with Chronic Heart Failure.
- Trial name
- NCT06348498
- Testing
- Jia Shen Tablet
- Where
- China
- Volunteers
- 18 people
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd
Age-related Macular Degeneration
A Phase Ⅱ Clinical Study of Sanhuangjingshimingwan in Wet( Neovascular)Age-related Macular Degeneration(wAMD) Subjects
The study is to evaluate the efficacy and safety of Sanhuangjingshimingwan in Wet AMD.
- Trial name
- NCT04486963
- Testing
- Sanhuangjingshimingwan
- Where
- 6 sites in China
- Volunteers
- 78 people
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd
Healthy
A Study to Evaluate the Tolerability and Pharmacokinetics of Jiashen Tablets in Healthy Subjects
Jiashen Tablets as an oral, compound traditional chinese medicine prepatations, have an effect on improvement of the heart failure.
- Trial name
- NCT04164290
- Testing
- Jiashen Tablets
- Where
- China
- Volunteers
- 70 people, healthy volunteers welcome
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd
Spondyloarthritis
Study of Jitongning Tablet to Treat Spondyloarthritis
This study is to investigate the efficacy and safety of Jitongning Tablet in improving joint function and pain symptoms in active axial spondyloarthritis (SpA) patients and to explore the optimal dosage.
- Trial name
- NCT03932019
- Testing
- Jitongning tablet(High-dose ), Jitongning tablet(Low-dose )
- Where
- 11 sites in China
- Volunteers
- 238 people
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd
Healthy Participants
A Study of Qishenyiqi Dripping Pills in Healthy Participants
This study will evaluate the safety and tolerability of Qishenyiqi Dripping Pills in healthy participants, following oral administration with multiple escalating dose of it.
- Trial name
- NCT04471298
- Testing
- Qishenyiqi dripping pills, 6 bags, Qishenyiqi dripping pills, 9 bags, Qishenyiqi dripping pills, 12 bags
- Where
- China
- Volunteers
- 36 people, healthy volunteers welcome
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd